Literature DB >> 2361019

Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients.

B Radovancevic1, S Poindexter, S Birovljev, V Velebit, H A McAllister, J M Duncan, D Vega, J Lonquist, C M Burnett, O H Frazier.   

Abstract

Allograft coronary artery disease (CAD) is the major determinant of long-term survival following heart transplantation (HTx). In a group of 210 heart transplant recipients, we diagnosed CAD in 54 (27.1%) by coronary angiography, postmortem examination or examination of the transplanted heart at the time of retransplantation. Retrospective analysis of potential risk factors for the development of CAD was performed for both immunological (rejection pattern, immunosuppressive therapy, cytomegalovirus [CMV] infection), and nonimmunological (hyperlipidemia, smoking, hypertension, diabetes mellitus, obesity) risk factors. The total number of rejection episodes correlated significantly with the occurrence of CAD (P less than 0.05), showing that patients who experienced two or more rejection episodes had an incidence of CAD of 40%, as opposed to a 23% incidence in patients who experienced no rejection. A composite rejection score derived from multivariate regression analysis of the severity, frequency, and timing of acute cardiac rejection episodes was found to correlate with the development of CAD (P less than 0.05). Postoperative arterial hypertension also correlated significantly with the onset of CAD (P less than 0.01), with a 92.6% incidence of hypertension in the group with CAD versus 76.3% in the group without CAD. Smoking after transplantation correlated significantly with the occurrence of CAD (P less than 0.05). There was no significant correlation with other analyzed factors in this group of patients. In this review, the development of CAD after heart transplantation correlated with treated allograft rejection. Aggressive treatment of hypertension and cessation of smoking may contribute to alleviation of this serious complication.

Entities:  

Mesh:

Year:  1990        PMID: 2361019     DOI: 10.1016/1010-7940(90)90207-g

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Update on pediatric heart transplantation. Long-term complications.

Authors:  R J Gajarski; D L Kearney; J K Price; S W Denfield
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Outcomes following cardiac transplantation in adults.

Authors:  Sai Bhagra; Jayan Parameshwar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-02-15

3.  Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.

Authors:  Oluwatoyosi A Onwuemene; Steven C Grambow; Chetan B Patel; Robert J Mentz; Carmelo A Milano; Joseph G Rogers; Ara D Metjian; Gowthami M Arepally; Thomas L Ortel
Journal:  J Clin Apher       Date:  2018-03-10       Impact factor: 2.821

Review 4.  The challenge of rejection and cardiac allograft vasculopathy.

Authors:  W G Cotts; M R Johnson
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

Review 5.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

6.  Guidelines for heart transplantation.

Authors:  N de Jonge; J H Kirkels; C Klöpping; J R Lahpor; K Caliskan; A P W M Maat; J Brügemann; M E Erasmus; R J M Klautz; H F Verwey; A Oomen; C H Peels; A E J Golüke; D Nicastia; M A C Koole; A H M M Balk
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

Review 7.  Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis.

Authors:  Boško Skorić; Maja Čikeš; Jana Ljubas Maček; Željko Baričević; Ivan Škorak; Hrvoje Gašparović; Bojan Biočina; Davor Miličić
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

Review 8.  Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy.

Authors:  Tracey M Ellimuttil; Kimberly Harrison; Allman T Rollins; Irene D Feurer; Scott A Rega; Jennifer Gray; Jonathan N Menachem
Journal:  Card Fail Rev       Date:  2021-11-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.